Impact of modified FOLFOX‐6 for patients with gastric cancer and a gastrointestinal obstruction

Aim Gastric cancer patients are normally treated with oral fluoropyrimidine and cisplatin or oxaliplatin; however, treating patients who also have a gastrointestinal obstruction is often difficult because of their poor oral intake. Instead, a modified (m)FOLFOX‐6 regimen is administered, even to pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asia-Pacific journal of clinical oncology 2019-10, Vol.15 (5), p.e91-e96
Hauptverfasser:	Yukami, Hiroki, Terazawa, Tetsuji, Goto, Masahiro, Aoki, Masahiko, Asaishi, Ken, Yamaguchi, Toshifumi, Kuwakado, Shin, Kii, Takayuki, Higuchi, Kazuhide
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy Cisplatin Female Fluorouracil - administration & dosage Gastric cancer Gastrointestinal Neoplasms - drug therapy Gastrointestinal Neoplasms - pathology gastrointestinal obstruction Humans Intestinal Obstruction - drug therapy Intestinal Obstruction - pathology Intravenous administration Leucovorin - administration & dosage Male mFOLFOX Middle Aged Oxaliplatin Oxaliplatin - administration & dosage Retrospective Studies Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Survival Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!